A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to ...

As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...

Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...

Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...

Neuronoff, Inc., a pioneer in minimally invasive neuromodulation solutions, today announced two major funding milestones ...

The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

Chrystal Starbird, a cancer researcher at the University of North Carolina School of Medicine, had been preparing to serve on ...

Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...

A trio of Democrats on Monday called on the Trump administration to restore full operations at the National Institutes of ...